Priorix

News

With measles cases rising, the UK has launched a campaign urging around a million families to book the new four-in-one MMRV vaccine.

News

With vaccine hesitancy leading to a rise in measles cases, the FDA's approval of GlaxoSmi

News

Hengrui's oral TPO agonist, hetrombopag, is the first in the class to be approved for thrombocytopenia caused by chemotherapy for solid tumours.

Digital

A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.